EYPT
Price
$16.07
Change
+$0.15 (+0.94%)
Updated
Jan 15, 11:26 AM (EDT)
Capitalization
1.32B
49 days until earnings call
Intraday BUY SELL Signals
LRMR
Price
$3.34
Change
-$0.07 (-2.05%)
Updated
Jan 15, 11:47 AM (EDT)
Capitalization
283.75M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EYPT vs LRMR

Header iconEYPT vs LRMR Comparison
Open Charts EYPT vs LRMRBanner chart's image
EyePoint
Price$16.07
Change+$0.15 (+0.94%)
Volume$200
Capitalization1.32B
Larimar Therapeutics
Price$3.34
Change-$0.07 (-2.05%)
Volume$1.94K
Capitalization283.75M
EYPT vs LRMR Comparison Chart in %
EYPT
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EYPT vs. LRMR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (EYPT: $15.92 vs. LRMR: $3.41)
Brand notoriety: EYPT and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 78% vs. LRMR: 124%
Market capitalization -- EYPT: $1.32B vs. LRMR: $283.75M
EYPT [@Biotechnology] is valued at $1.32B. LRMR’s [@Biotechnology] market capitalization is $283.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than LRMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 2 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 4 bearish.
  • LRMR’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than LRMR.

Price Growth

EYPT (@Biotechnology) experienced а -8.35% price change this week, while LRMR (@Biotechnology) price change was -0.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

EYPT is expected to report earnings on Mar 05, 2026.

LRMR is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($1.32B) has a higher market cap than LRMR($284M). LRMR YTD gains are higher at: -10.499 vs. EYPT (-12.863). LRMR has higher annual earnings (EBITDA): -139.43M vs. EYPT (-201.16M). EYPT has more cash in the bank: 204M vs. LRMR (175M). LRMR has less debt than EYPT: LRMR (4.35M) vs EYPT (21.3M). EYPT has higher revenues than LRMR: EYPT (42.3M) vs LRMR (0).
EYPTLRMREYPT / LRMR
Capitalization1.32B284M464%
EBITDA-201.16M-139.43M144%
Gain YTD-12.863-10.499123%
P/E RatioN/AN/A-
Revenue42.3M0-
Total Cash204M175M117%
Total Debt21.3M4.35M490%
FUNDAMENTALS RATINGS
EYPT vs LRMR: Fundamental Ratings
EYPT
LRMR
OUTLOOK RATING
1..100
6758
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3864
P/E GROWTH RATING
1..100
17100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (20) in the null industry is somewhat better than the same rating for EYPT (72) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew somewhat faster than EYPT’s over the last 12 months.

EYPT's Profit vs Risk Rating (69) in the Pharmaceuticals Major industry is in the same range as LRMR (100) in the null industry. This means that EYPT’s stock grew similarly to LRMR’s over the last 12 months.

EYPT's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as LRMR (100) in the null industry. This means that EYPT’s stock grew similarly to LRMR’s over the last 12 months.

EYPT's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as LRMR (64) in the null industry. This means that EYPT’s stock grew similarly to LRMR’s over the last 12 months.

EYPT's P/E Growth Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for LRMR (100) in the null industry. This means that EYPT’s stock grew significantly faster than LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTLRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 25 days ago
86%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTCO5.270.05
+0.96%
Fortitude Gold Corporation
GFASY0.03N/A
N/A
Gafisa S.A.
PLFRF43.20N/A
N/A
Palfinger AG
SYANY12.99N/A
N/A
Sydbank A/S
LTOUF44.00N/A
N/A
Larsen & Toubro Ltd.

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-0.06%
LYRA - EYPT
58%
Loosely correlated
-5.03%
ATHE - EYPT
54%
Loosely correlated
-2.29%
OCUL - EYPT
50%
Loosely correlated
+6.14%
IDYA - EYPT
47%
Loosely correlated
+5.53%
CLDX - EYPT
46%
Loosely correlated
+1.58%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with AMLX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
+2.40%
AMLX - LRMR
45%
Loosely correlated
+11.67%
EYPT - LRMR
44%
Loosely correlated
-0.06%
MLTX - LRMR
44%
Loosely correlated
+1.81%
XNCR - LRMR
42%
Loosely correlated
+3.66%
BCYC - LRMR
42%
Loosely correlated
+2.00%
More